Cargando…

Circulating Cytokines Reflect the Etiology-Specific Immune Environment in Cirrhosis and HCC

SIMPLE SUMMARY: Chronic liver diseases commonly cause severe scarring of the liver (cirrhosis) and liver cancer. The eventual progression of this scarring process to liver cancer is influenced by a variety of factors, including inflammatory cytokines (soluble mediators of cell communication). In ord...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beudeker, Boris J. B., Groothuismink, Zwier M. A., van der Eijk, Annemiek A., Debes, Jose D., Boonstra, Andre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563264/ https://www.ncbi.nlm.nih.gov/pubmed/36230823 http://dx.doi.org/10.3390/cancers14194900

Ejemplares similares

Hepatitis B core‐related antigen levels predict recurrence‐free survival in patients with HBV‐associated early‐stage hepatocellular carcinoma: results from a Dutch long‐term follow‐up study
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe
por: Beudeker, Boris J.B., et al.
Publicado: (2023)

Immune dissociation during acute hepatitis E infection
por: Debes, Jose D., et al.
Publicado: (2019)

Circulating biomarkers for early detection of hepatocellular carcinoma
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy
por: Spaan, Michelle, et al.
Publicado: (2016)

A mutation in the progesterone receptor predisposes to HEV infection in HIV‐positive patients
por: Debes, Jose D., et al.
Publicado: (2018)

Monocytes from Chronic HBV Patients React In Vitro to HBsAg and TLR by Producing Cytokines Irrespective of Stage of Disease
por: Boltjes, Arjan, et al.
Publicado: (2014)

MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort
por: Goble, Spencer, et al.
Publicado: (2023)

Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americans and Europeans
por: Ayoub, Alan, et al.
Publicado: (2023)

Negative Regulation of Hepatitis C Virus Specific Immunity Is Highly Heterogeneous and Modulated by Pegylated Interferon-Alpha/Ribavirin Therapy
por: Claassen, Mark A. A., et al.
Publicado: (2012)

Letter to the Editor: Entecavir Treatment Restores the Anti‐HBV Immune response?
por: Beudeker, Boris J.B., et al.
Publicado: (2021)

Differential gene expression, irrespective of circulating Hepatitis B Surface Antigen levels, between Inactive Carrier and Nucleos(t)ide Analogue-Treated Hepatitis B Virus patients
por: Montanari, Noé R, et al.
Publicado: (2020)

ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection
por: Maan, Raoel, et al.
Publicado: (2015)

HCC: RNA-Sequencing in Cirrhosis
por: Wang, Haoyu, et al.
Publicado: (2023)

The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma
por: Rico Montanari, Noe, et al.
Publicado: (2021)

Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis
por: Ismail, Saber A, et al.
Publicado: (2017)

Diabetes and the risk of cirrhosis and HCC: An analysis of the UK Biobank
por: Ye, Fangzhou, et al.
Publicado: (2023)

Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver Cirrhosis
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2021)

Progression of liver cirrhosis to HCC: an application of hidden Markov model
por: Bartolomeo, Nicola, et al.
Publicado: (2011)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
por: Huang, Yan, et al.
Publicado: (2022)

Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes
por: Ito, Takanori, et al.
Publicado: (2023)

Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies
por: Pal Chaudhary, Surendra, et al.
Publicado: (2023)

Evaluation of IL-28B Polymorphisms and Serum IP-10 in Hepatitis C Infected Chimpanzees
por: Verstrepen, Babs E., et al.
Publicado: (2012)

Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns
por: Soresi, Maurizio, et al.
Publicado: (2017)

More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
por: Zanetto, Alberto, et al.
Publicado: (2021)

Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
por: Huang, Daniel Q., et al.
Publicado: (2022)

Changing Etiology in Liver Cirrhosis in Sapporo, Japan
por: Kang, Jong-Hon, et al.
Publicado: (2018)

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant
por: Anugwom, Chimaobi M., et al.
Publicado: (2022)

Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): Impact of the PNPLA3 ( I148M ) risk allele
por: Kirchmeyer, Mélanie, et al.
Publicado: (2023)

Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection
por: Debes, Jose D., et al.
Publicado: (2016)

Validation of Whole Blood Rapid Diagnosis Test for Hepatitis B
por: Debes, Jose D., et al.
Publicado: (2020)

Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis
por: Jiang, Yingying, et al.
Publicado: (2020)

Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2016)

Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than ever
por: Tonon, Marta, et al.
Publicado: (2021)

Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC
por: Abed, Sally, et al.
Publicado: (2017)

Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis
por: Zhang, Ping, et al.
Publicado: (2018)

Aggressive primary gastric lymphoma (PGL) masquerading as hepatocellular cancer (HCC) in alcoholic cirrhosis
por: Ahmed, Moiz, et al.
Publicado: (2021)

Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials
por: Kraglund, Frederik, et al.
Publicado: (2023)

Infectious Agents and Xenobiotics in the Etiology of Primary Biliary Cirrhosis
por: Selmi, Carlo, et al.
Publicado: (2010)

Thromboelastography does not predict outcome in different etiologies of cirrhosis
por: Hugenholtz, Greg C.G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sai48kd3lm0trd6m27kva5fdhr